The California (Cal) serotype of infectious bronchitis virus (IBV) was isolated from layer flocks in southern California in the early 1980s. Since then, it has spread to the broiler-producing regions of central California, where it has been implicated in respiratory disease outbreaks in vaccinated flocks. Lack of a procedure for quickly identifying IBV serotypes in commercial chicken flocks has prevented the causal association of the IBV Cal serotype with respiratory disease outbreaks. A protein polymorphism has been identified in the matrix protein of the Cal serotype; it appears to be unique among other common serotypes of infectious bronchitis virus found in California. This polymorphism can be identified on western blots using raw or concentrated infectious allantoic fluid as the source material. Identification of the Cal serotype and of serotypes in the Mass and Conn groups can be performed rapidly using field samples from suspect flocks. The identification of this polymorphism provides an alternative method for the rapid identification of the Cal serotype of IBV.
Infectious bronchitis of chickens is caused by a highly infectious coronavirus, infectious bronchitis virus (IBV). Since its initial identification in 1931, IBV has proven to be a consistent problem in California poultry flocks. Attempts to control the disease caused by IBV have been hampered by the biological nature the Coronaviridae. These viruses are single-stranded RNA viruses containing the largest nonsegmented RNA genome of any RNA virus. 7, 33 Because of its size and molecular composition, IBV has a tendency to form new variant strains that are apparently not inhibited by commercial vaccines. 7, 13 Therefore, it is of great importance to chicken producers to identify the strains of IBV in their flocks so vaccination programs can be modified to account for the IBV strains present.
Identification of serotypes of IBV from field outbreaks typically involves the identification of the virus from field samples, usually through the use of virus isolation in embryonating chicken eggs, lack of hemagglutinating activity against chicken erythrocytes, visualization of the virus via electron microscopy to identify the specific coronavirus morphology, and the identification of the specific serotype using virus neutralization procedures. Often, 2-6 weeks will elapse before a positive identification can be made. In commercial broiler production, such a delay in identifi-cation of an infectious agent often means the results are not applicable to the current group of birds.
Rapid serologic tests such as the enzyme-linked immunosorbent assay (ELISA) assist in identifying an immunologic response to IBV but do not identify the serotype involved. Hemagglutination inhibition tests are unreliable in multiply vaccinated birds because of high levels of cross-reactivity among strains in the assay. 3 Newer methods such as the polymerase chain reaction (PCR), 16, 21, 22, 30, 32 cDNA dot-blot hybridization, 28 and restriction fragment length polymorphism (RFLP) 22 have all been developed to decrease the time needed to identify IBV strains, but they are currently available at only a few institutions because of the specialized equipment, facilities, and training necessary to perform these assays.
In California, the predominant strains of IBV identified include Mass 41 (M41), Connecticut (Conn), Arkansas 99 (Ark-99), and California (Cal), a recently isolated strain. 14 The first three strains are commonly included in commercial vaccines used extensively throughout the poultry-producing areas of California. Currently, no commercially produced vaccine for the Cal strain of IBV has been licensed for use in California.
In this study, we identified a polymorphism in the structural polypeptides of the Cal strain of IBV that allows its differentiation from the other common strains of IBV found in California poultry flocks. Techniques have been optimized so that the identification of all of the common strains of IBV found in California can be made in a few days, providing producers with results that may be immediately useful in their operations.
Materials and methods
Virus growth and purification. Reference viruses a were used for comparison with field strains. Field strains of virus were isolated from diagnostic cases submitted to the California Veterinary Diagnostic Laboratory System. Virus growth was performed in 8-10-day-old specific-pathogen-free (SPF) embryonating chicken eggs. b Virus (0.2 ml) was inoculated into the allantoic cavity, eggs were incubated at 37 C (82-85% humidity), and chorioallantoic fluid (CAF) was harvested 30-40 h postinoculation. Infectious CAF was used directly in the assay, or the virus was concentrated by dilution in TEN buffer (150 mM NaCl, 10mM Tris-HCl, 1 mM ethylenediaminetetraacetic acid (disodium), pH 7.4) followed by pelleting at 35,000 x g for 90 min through a 30% (w/w) sucrose cushion. Purified virus was prepared as previously described. 4 Polyclonal and monoclonal anti-IBV antisera. Monoclonal antibodies c directed against a group-specific matrix protein antigen (9:19:3d) and an epitope on the spike (S1) protein of the Mass (15:88:2c), Conn (9:40:3d), and Ark-99 (13:18: 2b) serotypes were used for confirmation of strain identity.
Polyclonal serotype-specific sera for each of the 4 serotypes used in this study were produced in SPF chickens b , which had been hatched and raised in isolation. The chickens were placed in Horsfall-Bauer isolation units at 7 wk of age, and after 1 wk of acclimation they were inoculated intratracheally with 10 7.4 EID 50 of a single serotype of IBV. Two weeks later, the chickens were reinoculated intravenously with 10 7.4 EID 50 of the homologous serotype. All birds were exsanguinated 2 wk following the second dose. Serum was separated, aliquoted, and stored at -70 C. Hemagglutination inhibition analysis of the resulting antisera showed a minimum 128fold difference in specificity for the homologous strain when tested against the heterologous strains.
Serum virus neutralization. The serum virus neutralization (SVN) procedure was based on the constant-virus, variable serum method. 12 Serotype-specific antisera were titrated against the homologous serotype to determine the IBV antibody titers. The antisera were then diluted to 10-20 antibody units (1 unit = dilution of antibody sufficient to neutralize 100-1,000 EID 50 of virus), mixed with 100-1,000 EID 50 of virus, and incubated at room temperature for 1 hr. Following incubation, 0.2 ml of serum-virus mixture was inoculated into 5 8-10-day-old SPF embryonating chicken eggs. The eggs were incubated at 37 C and candled daily to observe deaths. Deaths at 24 hr postinoculation were discarded as nonspecific. After 7 days, the eggs were chilled at 4 C, and the embryos were examined for lesions compatible with IBV. Virus neutralization was defined as the protection of embryos from IBV lesions at 7 days postinoculation.
Electrophoresis and immunoblotting of viral polypeptides. Viral polypeptides were separated at 30 mA on discontinuous 10% sodium dodecyl sulfate (SDS) polyacrylamide gels with 4% stacking gels in Tris : glycine buffer (192 mM glycine, 25 mM Tris, 0.1% SDS, pH 8.3) for approximately 2.5 hr. 23 For unpurified virus, 5 µg of total protein were used per lane. When concentrated or purified virus was used, a total of 1 µg was loaded.
Following polyacrylamide gel electrophoresis (PAGE), the proteins were blotted to nitrocellulose as previously described. 34 Protein transfer was performed at 60 V for 2-4 hr at room temperature in transfer buffer (192 mM glycine, 25 mM Tris, 20% methanol, pH 8.3).
The filters were blocked for 1 hr at room temperature in 5% nonfat dry milk in phosphate-buffered saline (PBS)-Tween 20 (0.05%), pH 7.4 (wash buffer) and treated with IBV antisera containing a mixture of the 4 strain-specific antisera, diluted 1:1,000. The filters were incubated for 18 hr at room temperature and washed 3 times. The filters were incubated at room temperature for 4 hr in peroxidase-conjugated rabbit anti-chicken IgG, H + L d diluted 1:750 in PBS-Tween 20. Following 3 washes, the bands were developed using 4-chloronapthol(0.5 mg/ml), H 2 O 2 (0.025%). After 10 min, the filters were rinsed in deionized water for 10 min and allowed to air dry.
Strain determination by dot-blot was performed using monoclonal antibodies as the primary antibody. Because we did not have a Cal-specific monoclonal antibody, the Cal strain was assumed by the presence of a reaction to the groupspecific IBV antibody and a lack of reaction to the other serotype-specific antibodies.
The dot-blot was performed as follows. Infectious CAF (25 µl) was dotted onto 0.2-µm nitrocellulose filters. e The filter was allowed to air dry and was then blocked in a 5% solution of nonfat dry milk for 1 hr at room temperature. After briefly rinsing with deionized water, the filters were treated with the appropriate monoclonal antibodies diluted 1:5,000 in PBS-Tween 20. Peroxidase-conjugated sheep antimouse IgG d was diluted 1:300 in PBS-Tween 20 and incubated with the filters for 4 hr at room temperature. The filters were washed 3 times and developed as above.
Results
Identification of M-protein polymorphism. The immunoblot results shown in Figure 1 demonstrate the pattern of proteins observed when 5 µg of total protein from infectious CAF is used as the source material for PAGE. Purified viruses (1 µg/lane) representing the 4 serotypes were included to assist in identifying specific viral proteins. The S-proteins have a molecular mass of approximately 94 kD and 96 kD. The N-protein, which is the predominant protein of the virus, shows a dark band at approximately 54 kD, and M-proteins appear as a polymorphic set of proteins ranging from approximately 23 kD to 33 kD. The polyclonal antiserum mixture allowed identification of a number of nonviral proteins, but these did not interfere with the ability to identify the viral proteins.
Although the S and N proteins of all of the strains were similar in molecular weight, substantial differences were noticed in the M proteins because the native M protein is variably glycosylated during viral matu- ration in the infected cells. The variation is determined by the glycosylation sites on the native protein. 6 In this procedure, the major bands associated with the M proteins of the reference Mass-41 strain of IBV have approximate molecular masses of 32.5 kD, 31 kD, and 28 kD. The Conn and Ark-99 reference strains of IBV both have M proteins with molecular masses of 27 kD, 26 kD, and 23 kD. Field strains of IBV corresponding to this type of IBV were often lacking the smallest MW protein (Fig. 1: lanes 3 and 6) . The Cal strain has M proteins with molecular masses that are intermediate with respect to the other strains of IBV, at 30 kD and 28.5 kD. A third band was never identified for the Cal strain. This pattern of matrix protein migration has not been reported for any other serotype of IBV. Figure 2 shows the same set of viruses stained using the group-specific anti-IBV monoclonal antibody. The 9:19:3d antibody is specific for the native M protein of IBV, and the protein polymorphism seen using the polyclonal antisera is due to molecular mass variations in the viral M protein. The protein polymorphism in the Cal strain of IBV is unique.
To determine the ability of this procedure to detect mixed infections of IBV or of IBV and other viruses, dual mixtures of all IBV strains and of IBV and Newcastle disease virus (NDV) were tested using PAGE (Fig. 3) . Although most mixed infections can be easily discriminated, the Mass and Cal mixture of IBV strains is difficult to discriminate. Because the intermediate band of the Mass strain and the upper band of the Cal strain differ in molecular mass by only 1 kD and the lower bands of both differ by only 0.5 kD, the discrimination of these 2 strains can be problematic. Initial experiments with gels containing higher percentages of polyacrylamide have shown promise in further separating these strains (data not shown).
Differentiation of Conn and Ark-99 IBV. The com-
parable protein profile seen with the Conn and Ark-99 strains of IBV do not allow differentiation of these strains by PAGE alone. Dot-blot analysis of viruses with this pattern of polypeptides can provide the identification of the serotype. The strain-specific IBV monoclonal antibodies detect differences in the S1 protein of the virus. 19 Figure 4 shows the results of dotblot analysis of the 4 strains of IBV using monoclonal antibodies against the group antigen of IBV and against the S1 protein of the Mass-41, Conn, and Ark-99 strains of IBV. Although the Cal strain of IBV reacts with the group-specific antibody, it does not react with any of the monoclonal antibodies against the S1 protein. Thus, the novel protein polymorphism seen on PAGE and the absence of reactivity with strain-specific monoclonal antibodies confirms the unique nature of the Cal strain of IBV and suggests that the polymorphism seen in the M protein of the Cal strain of IBV is not the only difference between Cal and the other strains of IBV.
SVN. Table 1 shows the correlation among the three procedures used to identify IBV reference and field strains. These results show that the Cal serotype of IBV as identified by SVN correlates closely with the polymorphism identified by PAGE. The Cal strain could not be tested directly via dot-blot; however, the lack of reactivity with the other strain-specific monoclonal antibodies again suggests that the Cal strain is distinct from the other strains tested. One of the field isolates (Table 1, isolate 2) could not be serotyped using the SVN procedure because it did not react with any of the reference antisera. With the dot-blot procedure, 2 of the strains typed via PAGE and by SVN (isolates 3 and 6) did not react with any of the strain-specific monoclonal antibodies, most likely because of the loss of viral spikes during the purification.
Discussion
Methods for the identification of serotypes of IBV have gone thorough a number of modifications over the last 25 years. The first established method for differentiating strains was the SVN test 10 A large amount of time, effort, and expense in the identification of a single strain of virus is required, both in the production of specific antiserum and in the SVN assay itself. Other procedures that identify differences among strains, such as plaque reduction assays, 15 neutralization in tracheal organ culture,11,1 7 and neutralization of immunofluorescent foci 9 have been reported but have not been widely accepted as routine diagnostic procedures.
A commonly used assay, hemagglutination inhibition, is complicated by the fact that many strains of IBV do not readily hemagglutinate, even after phospholipase treatment. l Newer procedures such as PCR 16, 21 and detection using monoclonal antibodies 19, 30, 32 require the existence of either strain-specific nucleotide primers or monoclonal antibodies for each of the different viruses, and the tests are often technically difficult to perform. Many of the above methods rely on the functional neutralization of infectivity to distinguish between serotypes. Work on IBV at the molecular level has shown that there are considerable differences between strains of IBV, at both the protein and nucleic acid levels, that do not correspond with the serotypic differences. 6, 20 Additionally, there is evidence that multiple determinants on the virion are responsible for its infectivity and propagation in chickens. 18, 25 From a diagnostic standpoint, procedures that can rapidly differentiate strains of IBV are desirable so that measures may be taken to minimize disease within a currently affected flock. The identification of unique physical markers within the IBV virion can be made rapidly without the need for biological assays. Although these physical assays may not correspond to specific serotypes, they may provide enough information for the producer to act while functional assays are in progress.
The native structural polypeptides of IBV have been studied intensively. 2, 5, 24, 27, 31, 33, 35, 36 IBV has been divided into 2 categories, the Conn group and the Mass group, based on the migration of IBV matrix polypeptides on PAGE. 8, 26, 29, 31 Of the 13 serotypes analyzed in these studies, all fell into these 2 groups. 29 The pattern seen for the M41, Conn, and Ark-99 strains of IBV reported here are identical to those previously reported.
In this study, a unique physical marker was identified for the Cal strain of IBV. The protein polymorphism of the M-proteins in this virus has not previously been reported. In all functional assays of IBV isolates containing this matrix pattern, the virus has been classified as the Cal strain. Further studies using PCR have also classified nearly 85% of these viruses as the Cal strain, 37 verifying that this matrix polymorphism is unique and differentiating the Cal strain from all other strains of IBV found in commercial poultry in California. Additional studies comparing matrix protein patterns from isolates not commonly found in California would be of great value in determining the physical relationship of the Cal serotype of IBV with serotypes found in other regions of the USA.
